Published in J Immunol on February 03, 2010
Epigenetic mechanisms in Alzheimer's disease. Neurobiol Aging (2011) 3.83
Mir-34: a new weapon against cancer? Mol Ther Nucleic Acids (2014) 1.81
Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J Clin Invest (2011) 1.61
Noncoding flavivirus RNA displays RNA interference suppressor activity in insect and Mammalian cells. J Virol (2012) 1.58
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance. J Neuroinflammation (2012) 1.52
MicroRNA in ischemic stroke etiology and pathology. Physiol Genomics (2010) 1.48
MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease. Immune Netw (2011) 1.29
MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological disease. Cell Death Dis (2010) 1.26
MicroRNA miR-29c down-regulation leading to de-repression of its target DNA methyltransferase 3a promotes ischemic brain damage. PLoS One (2013) 1.19
The Role of MicroRNAs in Regulatory T Cells and in the Immune Response. Immune Netw (2011) 1.13
Noncoding subgenomic flavivirus RNA: multiple functions in West Nile virus pathogenesis and modulation of host responses. Viruses (2014) 1.13
Altered microRNA signatures in sputum of patients with active pulmonary tuberculosis. PLoS One (2012) 1.12
MicroRNAs: new regulators of Toll-like receptor signalling pathways. Biomed Res Int (2014) 1.11
MicroRNA regulation of innate immune responses in epithelial cells. Cell Mol Immunol (2011) 1.11
A plasma microRNA signature of acute lentiviral infection: biomarkers of central nervous system disease. AIDS (2011) 1.10
miRNA profiles of monocyte-lineage cells are consistent with complicated roles in HIV-1 restriction. Viruses (2012) 1.09
High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1. J Virol (2013) 1.02
Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture. PLoS One (2013) 0.99
MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients. Int J Mol Sci (2013) 0.99
Respiratory syncytial virus regulates human microRNAs by using mechanisms involving beta interferon and NF-κB. MBio (2012) 0.93
microRNA response to Listeria monocytogenes infection in epithelial cells. Int J Mol Sci (2012) 0.93
Innate antiviral response: role in HIV-1 infection. Viruses (2011) 0.93
MicroRNAs in Human Diseases: From Autoimmune Diseases to Skin, Psychiatric and Neurodegenerative Diseases. Immune Netw (2011) 0.90
Inhibition of TLR8- and TLR4-induced Type I IFN induction by alcohol is different from its effects on inflammatory cytokine production in monocytes. BMC Immunol (2011) 0.90
SIV replication is directly downregulated by four antiviral miRNAs. Retrovirology (2013) 0.89
MicroRNAs in Human Diseases: From Lung, Liver and Kidney Diseases to Infectious Disease, Sickle Cell Disease and Endometrium Disease. Immune Netw (2011) 0.89
Liposome delivery of microRNA-145 to mesenchymal stem cells leads to immunological off-target effects mediated by RIG-I. Mol Ther (2013) 0.88
MicroRNAs mediating CNS inflammation: Small regulators with powerful potential. Brain Behav Immun (2015) 0.87
Differential expression of miRNAs in enterovirus 71-infected cells. Virol J (2015) 0.86
Role of microRNAs in stroke and poststroke depression. ScientificWorldJournal (2013) 0.86
Tristetraprolin expression and microRNA-mediated regulation during simian immunodeficiency virus infection of the central nervous system. Mol Brain (2013) 0.86
MicroRNA as Type I Interferon-Regulated Transcripts and Modulators of the Innate Immune Response. Front Immunol (2015) 0.86
Innate immune evasion strategies by human immunodeficiency virus type 1. ISRN AIDS (2013) 0.85
Neuroprotection of microRNA in neurological disorders (Review). Biomed Rep (2014) 0.84
Long Non-Coding RNAs Involved in Immune Responses. Front Immunol (2014) 0.84
MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy. Viruses (2012) 0.84
Cellular microRNA miR-26a suppresses replication of porcine reproductive and respiratory syndrome virus by activating innate antiviral immunity. Sci Rep (2015) 0.83
An integrated approach identifies IFN-regulated microRNAs and targeted mRNAs modulated by different HCV replicon clones. BMC Genomics (2011) 0.82
Post-transcriptional regulation of interferons and their signaling pathways. J Interferon Cytokine Res (2014) 0.82
MiR-26a enhances autophagy to protect against ethanol-induced acute liver injury. J Mol Med (Berl) (2015) 0.81
Circulating miRNA signatures of early pregnancy in cattle. BMC Genomics (2016) 0.81
Prevention of SHIV transmission by topical IFN-β treatment. Mucosal Immunol (2016) 0.80
The role of the 3'UTR region in the regulation of the ACVR1/Alk-2 gene expression. PLoS One (2012) 0.79
Small RNA analysis in Sindbis virus infected human HEK293 cells. PLoS One (2013) 0.79
A major locus on chromosome 3p22 conferring predisposition to human herpesvirus 8 infection. Eur J Hum Genet (2012) 0.78
Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release. J Virol (2015) 0.78
Association between microRNA polymorphisms and humoral immunity to hepatitis B vaccine. Hum Vaccin Immunother (2013) 0.78
SAMHD1 transcript upregulation during SIV infection of the central nervous system does not associate with reduced viral load. Sci Rep (2016) 0.78
Double-stranded microRNA mimics can induce length- and passenger strand-dependent effects in a cell type-specific manner. RNA (2015) 0.78
Analysis of microRNA and Gene Expression Profiles in Multiple Sclerosis: Integrating Interaction Data to Uncover Regulatory Mechanisms. Sci Rep (2016) 0.77
Transcriptional analysis of porcine intestinal mucosa infected with Salmonella Typhimurium revealed a massive inflammatory response and disruption of bile acid absorption in ileum. Vet Res (2016) 0.76
Cellular microRNAs and picornaviral infections. RNA Biol (2014) 0.76
Identification of TLR2 and TLR4‑induced microRNAs in human mesenchymal stem cells and their possible roles in regulating TLR signals. Mol Med Rep (2016) 0.76
miR-4443 Participates in the Malignancy of Breast Cancer. PLoS One (2016) 0.75
Changes in circulating microRNA levels can be identified as early as day 8 of pregnancy in cattle. PLoS One (2017) 0.75
Identification and Characterization of Liver MicroRNAs of the Chinese Tree Shrew via Deep Sequencing. Hepat Mon (2015) 0.75
Emergence of miR-34a in radiation therapy. Crit Rev Oncol Hematol (2016) 0.75
The Role of MicroRNA in Hepatitis C Virus Replication. J Clin Transl Hepatol (2013) 0.75
Editorial: Functions of Non-Coding RNA in Innate Immunity. Front Immunol (2015) 0.75
Retinal expression of small non-coding RNAs in a murine model of proliferative retinopathy. Sci Rep (2016) 0.75
Altered hippocampal microRNA expression profiles in neonatal rats caused by sevoflurane anesthesia: MicroRNA profiling and bioinformatics target analysis. Exp Ther Med (2016) 0.75
The human genome browser at UCSC. Genome Res (2002) 168.23
BLAT--the BLAST-like alignment tool. Genome Res (2002) 126.78
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res (2006) 39.25
miRBase: tools for microRNA genomics. Nucleic Acids Res (2007) 38.61
MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell (2007) 38.42
Human MicroRNA targets. PLoS Biol (2004) 34.51
A mammalian microRNA expression atlas based on small RNA library sequencing. Cell (2007) 34.03
The microRNA Registry. Nucleic Acids Res (2004) 29.45
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res (2005) 29.17
CpG islands in vertebrate genomes. J Mol Biol (1987) 23.16
The role of site accessibility in microRNA target recognition. Nat Genet (2007) 18.52
Fast and effective prediction of microRNA/target duplexes. RNA (2004) 18.10
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell (2007) 14.58
Phylogenetic shadowing and computational identification of human microRNA genes. Cell (2005) 13.24
LNA-mediated microRNA silencing in non-human primates. Nature (2008) 11.45
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell (2009) 11.10
Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell (2007) 9.51
Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature (2007) 7.04
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene (2007) 6.55
miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A (2008) 6.24
Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood (2007) 5.14
p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A (2009) 5.05
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev (2009) 4.15
MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci U S A (2009) 3.97
Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci U S A (2009) 3.76
Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe (2008) 3.73
MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol (2009) 3.72
Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat Biotechnol (2009) 3.66
microRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet (2007) 3.63
MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum (2009) 3.44
Redefining microRNA targets. Curr Biol (2009) 3.37
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood (2008) 3.03
MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol (2009) 2.89
MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence. Nucleic Acids Res (2005) 2.87
MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis. J Biol Chem (2008) 2.81
MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components. Mol Immunol (2007) 2.24
MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology (2009) 2.04
miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ (2009) 1.82
Immune responses to RNA-virus infections of the CNS. Nat Rev Immunol (2003) 1.74
Contribution of interferon-beta to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide. J Biol Chem (2006) 1.70
Dicer is regulated by cellular stresses and interferons. Mol Immunol (2008) 1.69
Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a. Proc Natl Acad Sci U S A (2009) 1.64
miR-17 family of microRNAs controls FGF10-mediated embryonic lung epithelial branching morphogenesis through MAPK14 and STAT3 regulation of E-Cadherin distribution. Dev Biol (2009) 1.56
Prediction of glycosylation sites using random forests. BMC Bioinformatics (2008) 1.55
Coordinated regulation of SIV replication and immune responses in the CNS. PLoS One (2009) 1.49
Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop. J Immunol (2009) 1.42
Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun (2009) 1.41
Postinduction repression of the beta-interferon gene is mediated through two positive regulatory domains. Proc Natl Acad Sci U S A (1990) 1.37
CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells. Proc Natl Acad Sci U S A (1997) 1.31
Bruton's tyrosine kinase is involved in miR-346-related regulation of IL-18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes. J Immunol (2009) 1.30
Cancerous miRNAs and their regulation. Cell Cycle (2008) 1.29
Deadenylation of interferon-beta mRNA is mediated by both the AU-rich element in the 3'-untranslated region and an instability sequence in the coding region. Eur J Biochem (2003) 1.25
Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS. J Neuroimmune Pharmacol (2006) 1.21
Innate immune responses and control of acute simian immunodeficiency virus replication in the central nervous system. J Neurovirol (2004) 1.14
Interferon gene expression following HIV type 1 infection of monocyte-derived macrophages. AIDS Res Hum Retroviruses (2004) 1.13
Longitudinal analysis of simian immunodeficiency virus (SIV) replication in the lungs: compartmentalized regulation of SIV. J Infect Dis (2006) 1.06
CUGBP1 is required for IFNbeta-mediated induction of dominant-negative CEBPbeta and suppression of SIV replication in macrophages. J Immunol (2007) 1.00
A role for Stat1 in the regulation of lipopolysaccharide-induced interleukin-1beta expression. J Interferon Cytokine Res (2006) 1.00
Rhythmic expression of microRNA-26a regulates the L-type voltage-gated calcium channel alpha1C subunit in chicken cone photoreceptors. J Biol Chem (2009) 0.99
Neutralizing type I IFN antibodies trigger an IFN-like response in endothelial cells. J Immunol (2008) 0.98
Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved. Curr Opin Pharmacol (2008) 0.96
Identification and characterization of the interferon-beta-mediated p53 signal pathway in human peripheral blood mononuclear cells. Immunology (2009) 0.84
Interferon research BC (before cloning). Curr Top Microbiol Immunol (2007) 0.81
A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy. J Virol (2009) 2.10
Minocycline attenuates HIV infection and reactivation by suppressing cellular activation in human CD4+ T cells. J Infect Dis (2010) 1.70
Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients. Retrovirology (2012) 1.62
Platelet activation and platelet-monocyte aggregate formation contribute to decreased platelet count during acute simian immunodeficiency virus infection in pig-tailed macaques. J Infect Dis (2013) 1.57
Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Mol Endocrinol (2004) 1.56
The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus-associated neurological disease: from mechanism to treatment. J Neurovirol (2008) 1.54
Activation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.50
Coordinated regulation of SIV replication and immune responses in the CNS. PLoS One (2009) 1.49
Severe depletion of CD4+ CD25+ regulatory T cells from the intestinal lamina propria but not peripheral blood or lymph nodes during acute simian immunodeficiency virus infection. J Virol (2007) 1.47
Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism. J Neurosci (2011) 1.43
Hairless triggers reactivation of hair growth by promoting Wnt signaling. Proc Natl Acad Sci U S A (2005) 1.41
Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling. J Biol Chem (2003) 1.41
A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease. J Neurovirol (2002) 1.41
Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA. J Infect Dis (2010) 1.37
Homology modeling of the transmembrane domain of the human calcium sensing receptor and localization of an allosteric binding site. J Biol Chem (2003) 1.23
Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model. J Infect Dis (2006) 1.19
Searching for clues: tracking the pathogenesis of human immunodeficiency virus central nervous system disease by use of an accelerated, consistent simian immunodeficiency virus macaque model. J Infect Dis (2002) 1.18
Novel pathway for induction of latent virus from resting CD4(+) T cells in the simian immunodeficiency virus/macaque model of human immunodeficiency virus type 1 latency. J Virol (2006) 1.16
Innate immune responses and control of acute simian immunodeficiency virus replication in the central nervous system. J Neurovirol (2004) 1.14
Eradication of HIV from the brain: reasons for pause. AIDS (2011) 1.10
A plasma microRNA signature of acute lentiviral infection: biomarkers of central nervous system disease. AIDS (2011) 1.10
Role of microglial cells in selective replication of simian immunodeficiency virus genotypes in the brain. J Virol (2003) 1.10
From mice to macaques--animal models of HIV nervous system disease. Curr HIV Res (2006) 1.09
The thyroid hormone-regulated corepressor hairless associates with histone deacetylases in neonatal rat brain. Mol Endocrinol (2002) 1.09
miRNA profiles of monocyte-lineage cells are consistent with complicated roles in HIV-1 restriction. Viruses (2012) 1.09
A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system. Curr Opin HIV AIDS (2011) 1.09
Hairless and Wnt signaling: allies in epithelial stem cell differentiation. Cell Cycle (2006) 1.08
Central nervous system correlates of behavioral deficits following simian immunodeficiency virus infection. J Neurovirol (2003) 1.08
Longitudinal analysis of simian immunodeficiency virus (SIV) replication in the lungs: compartmentalized regulation of SIV. J Infect Dis (2006) 1.06
Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages. J Immunol (2010) 1.05
Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology. J Virol (2002) 1.04
Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection. J Leukoc Biol (2012) 1.03
Detection of microbial translocation in HIV and SIV infection using the Limulus amebocyte lysate assay is masked by serum and plasma. PLoS One (2012) 1.01
CUGBP1 is required for IFNbeta-mediated induction of dominant-negative CEBPbeta and suppression of SIV replication in macrophages. J Immunol (2007) 1.00
Hydrogen bonding at a conserved threonine in lentivirus capsid is required for virus replication. J Virol (2003) 0.99
A unique insertion/duplication in the VDR gene that truncates the VDR causing hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. Arch Biochem Biophys (2006) 0.98
Heat shock protein 90 and ErbB2 in the cardiac response to doxorubicin injury. Cancer Res (2007) 0.93
Progressive selection for neurovirulent genotypes in the brain of SIV-infected macaques. AIDS (2006) 0.92
Replication-competent simian immunodeficiency virus (SIV) Gag escape mutations archived in latent reservoirs during antiretroviral treatment of SIV-infected macaques. J Virol (2011) 0.92
Simian immunodeficiency virus infection in the brain and lung leads to differential type I IFN signaling during acute infection. J Immunol (2011) 0.91
An internal ribosome entry site promotes translation of a novel SIV Pr55(Gag) isoform. Virology (2006) 0.90
Calcium sensing receptor activation by a calcimimetic suggests a link between cooperativity and intracellular calcium oscillations. J Biol Chem (2002) 0.90
SIV replication is directly downregulated by four antiviral miRNAs. Retrovirology (2013) 0.89
Canonical type I IFN signaling in simian immunodeficiency virus-infected macrophages is disrupted by astrocyte-secreted CCL2. J Immunol (2012) 0.88
Induction of innate immune responses by SIV in vivo and in vitro: differential expression and function of RIG-I and MDA5. J Infect Dis (2011) 0.87
Evidence for miRNA expression differences of HIV-1-positive, treatment-naive patients and elite suppressors: a re-analysis. Blood (2012) 0.87
Tristetraprolin expression and microRNA-mediated regulation during simian immunodeficiency virus infection of the central nervous system. Mol Brain (2013) 0.86
Regulation of CCL2 expression by an upstream TALE homeodomain protein-binding site that synergizes with the site created by the A-2578G SNP. PLoS One (2011) 0.86
Initiation of HAART during acute simian immunodeficiency virus infection rapidly controls virus replication in the CNS by enhancing immune activity and preserving protective immune responses. J Neurovirol (2010) 0.86
PrPC, the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation. Am J Pathol (2010) 0.84
CD4-independent entry and replication of simian immunodeficiency virus in primary rhesus macaque astrocytes are regulated by the transmembrane protein. J Virol (2005) 0.83
Minocycline suppresses activation of nuclear factor of activated T cells 1 (NFAT1) in human CD4+ T cells. J Biol Chem (2011) 0.83
Quinolinic acid/tryptophan ratios predict neurological disease in SIV-infected macaques and remain elevated in the brain under cART. J Neurovirol (2015) 0.81
SIV-specific T lymphocyte responses in PBMC and lymphoid tissues of SIV-infected pigtailed macaques during suppressive combination antiretroviral therapy. J Med Primatol (2005) 0.81
Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques. AIDS (2017) 0.80
Tissue-specific interferon alpha subtype response to SIV infection in brain, spleen, and lung. J Interferon Cytokine Res (2012) 0.80
SIV/macaque model of HIV infection in cocaine users: minimal effects of cocaine on behavior, virus replication, and CNS inflammation. J Neuroimmune Pharmacol (2011) 0.80
Quantitation of gene expression in formaldehyde-fixed and fluorescence-activated sorted cells. PLoS One (2013) 0.80
Early emergence and selection of a SIV-LTR C/EBP site variant in SIV-infected macaques that increases virus infectivity. PLoS One (2012) 0.79
Phosphorylation and proteolytic cleavage of gag proteins in budded simian immunodeficiency virus. J Virol (2005) 0.79
RON receptor tyrosine kinase, a negative regulator of inflammation, is decreased during simian immunodeficiency virus-associated central nervous system disease. J Immunol (2013) 0.79
Induction of antibody-mediated neutralization in SIVmac239 by a naturally acquired V3 mutation. Virology (2010) 0.78
Human calcium-sensing receptor can be suppressed by antisense sequences. Biochem Biophys Res Commun (2003) 0.77
SIV antigen immunization induces transient antigen-specific T cell responses and selectively activates viral replication in draining lymph nodes in retroviral suppressed rhesus macaques. Retrovirology (2011) 0.76
The SIVmac239 Pr55Gag isoform, SIV p43, suppresses proteolytic cleavage of Pr55Gag. Virology (2006) 0.75
TRIM19-positive and TRIM19-negative cells in and around a perivascular cuff of CD68-positive macrophages. AIDS Res Hum Retroviruses (2014) 0.75
Protein kinase CK2 phosphorylates the Nef protein from a neurovirulent simian immunodeficiency virus. Virology (2006) 0.75
Conserved serines in simian immunodeficiency virus capsid are required for virus budding. Virology (2005) 0.75